Erectile Dysfunction

Improving sexual health in men with prostate cancer: Randomised controlled trial of exercise and psychosexual therapies - Abstract

BACKGROUND: Despite being a critical survivorship care issue, there is a clear gap in current knowledge of the optimal treatment of sexual dysfunction in men with prostate cancer.

Read more...

Association between erectile dysfunction and echocardiographic variables of ventricular hypertrophy and diastolic function in hypertensive patients with type 2 diabetes mellitus: A cross-sectional study - Abstract

BACKGROUND: This study was conducted among individuals with diabetes and hypertension in order to assess the prevalence of erectile dysfunction (ED) and the association between ED and cardiovascular risk variables such as echocardiographic changes.

Read more...

Low-intensity shock wave therapy and its application to erectile dysfunction - Abstract

Although phosphodiesterase type 5 inhibitors (PDE5Is) are a revolution in the treatment of erectile dysfunction (ED) and have been marketed since 1998, they cannot restore pathological changes in the penis.

Read more...

Impact of the change in urinary and sexual function on health-related quality of life after once daily low-dose mirodenafil treatment in patients with organic erectile dysfunction - Abstract

Objective: We aimed to evaluate whether changes in urinary and sexual function can influence health-related quality of life.

Read more...

Erectile dysfunction in the cardiology practice-a patients' perspective - Abstract

BACKGROUND: Erectile dysfunction (ED) is an independent risk factor for cardiovascular events sharing mutual risk factors with coronary artery disease.

Read more...

Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction - Abstract

The enzyme phosphodiesterase-5 (PDE-5), widely distributed in the heart, smooth muscle, and blood vessels, catalyzes the hydrolysis of cyclic guanosine monophosphate (cGMP), a potent vasodilator, and is also a nitric oxide (NO) donor.

Read more...

All men with vasculogenic erectile dysfunction require a cardiovascular workup - Abstract

An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk.

Read more...

The real-life perception of efficacy, attitude, satisfaction and safety of vardenafil therapy (REPEAT): A prospective, non-interventional, observational study - Abstract

This study assessed the improvement in relationship quality, effectiveness and safety associated with vardenafil for the treatment of erectile dysfunction (ED).

Read more...

Should men with mild erectile dysfunction be closely evaluated for cardiovascular diseases in the Korean population? - Abstract

This study compared demographic characteristics and prevalence of cardiovascular comorbidities between men with mild erectile dysfunction (ED) and men with more severe ED.

Read more...

Page 1 of 76